Corbus Pharmaceuticals Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2013 to Q3 2024.
  • Corbus Pharmaceuticals Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.5M, a 63.4% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$46.2M, a 0.98% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2023 was -$45.1M, a 13.2% decline from 2022.
  • Corbus Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2022 was -$39.8M, a 28.9% increase from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. annual Operating Income (Loss) for 2021 was -$56M, a 54.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$46.2M -$15.5M -$6.02M -63.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$40.2M -$11M -$2.8M -34.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$37.4M -$9.62M +$7.67M +44.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$45.1M -$10.1M +$694K +6.42% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$45.8M -$9.49M -$1.31M -16% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$44.5M -$8.19M +$4.15M +33.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$48.6M -$17.3M -$8.78M -103% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$39.8M -$10.8M -$798K -7.99% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$39M -$8.18M +$5.69M +41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$44.7M -$12.3M +$4.36M +26.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$49.1M -$8.52M +$6.9M +44.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$56M -$10M +$10.8M +52% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$66.8M -$13.9M +$20.1M +59.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$86.9M -$16.7M +$21.4M +56.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$108M -$15.4M +$14.5M +48.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$123M -$20.8M +$6.38M +23.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$129M -$34M -$8.88M -35.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$120M -$38.1M -$39.8M -2337% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$80.5M -$29.9M -$3.36M -12.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$77.1M -$27.2M -$9.6M -54.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$67.5M -$25.1M -$10.2M -68.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$57.3M $1.71M +$14.1M Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 -$71.4M -$26.5M -$14.7M -124% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$56.7M -$17.6M -$6.73M -62% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$50M -$14.9M -$7.94M -114% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$42.1M -$12.4M -$5.1M -70% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$37M -$11.9M -$4.41M -59.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$32.6M -$10.9M -$3.29M -43.4% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-12
Q3 2017 -$29.3M -$6.96M -$1.62M -30.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$27.7M -$7.29M -$3.1M -74% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$24.6M -$7.45M -$4.57M -158% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$20M -$7.57M -$5.07M -203% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$14.9M -$5.33M -$3.08M -137% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$11.8M -$4.19M -$1.63M -63.6% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$10.2M -$2.89M -$1.35M -88.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$8.85M -$2.5M -$1.24M -98.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$7.61M -$2.25M -$1.44M -176% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$6.18M -$2.56M -$2.1M -452% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$4.08M -$1.54M -$1.43M -1353% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$2.65M -$1.26M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$818K -$773K -1704% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$464K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$106K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 -$45.3K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.